- Report
- March 2026
- 144 Pages
Global
From €3722EUR$3,999USD£3,113GBP
- Report
- February 2026
- 141 Pages
Global
From €3722EUR$3,999USD£3,113GBP
- Report
- August 2026
- 148 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- August 2026
- 120 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- August 2026
- 120 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- July 2026
- 114 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- July 2026
- 170 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- July 2026
- 114 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- April 2026
- 120 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- April 2026
- 115 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- May 2026
- 350 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- May 2026
- 154 Pages
Global
From €3676EUR$3,950USD£3,074GBP
- Report
- May 2026
- 151 Pages
Global
From €3676EUR$3,950USD£3,074GBP
- Report
- May 2026
- 146 Pages
Global
From €3676EUR$3,950USD£3,074GBP
- Report
- January 2026
- 147 Pages
Global
From €3676EUR$3,950USD£3,074GBP
- Report
- August 2026
- 160 Pages
Global
From €3090EUR$3,320USD£2,584GBP
€3862EUR$4,150USD£3,230GBP
- Report
- August 2026
- 149 Pages
Global
From €3676EUR$3,950USD£3,074GBP
- Report
- May 2026
- 153 Pages
Global
From €3676EUR$3,950USD£3,074GBP
- Report
- January 2026
- 149 Pages
Global
From €3676EUR$3,950USD£3,074GBP
- Report
- February 2026
- 150 Pages
Global
From €4514EUR$4,850USD£3,775GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more